Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Beaumont-Azuar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|March 15, 2018
Donor-specific HLA antibody-mediated complement activation is a significant indicator of antibody-mediated rejection and poor long-term graft outcome during lung transplantation: a single center cohort studyAntoine Roux, Kimberly A Thomas, Edouard Sage, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
First use of imlifidase desensitization in a highly sensitized lung transplant candidate: a case reportAntoine Roux, Vincent Bunel, Natalia Belousova, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
High Emergency Lung Transplantation: dramatic decrease of waiting list death rate without relevant higher post-transplant mortalityAntoine Roux, Laurence Beaumont-Azuar, Abdul Monem Hamid, et al.
Frontiers in Medicine|October 28, 2017
Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung TransplantationAntoine Roux, Ines Bendib Le Lan, Sonia Holifanjaniaina, et al.
JHLT Open|March 27, 2025
Antireflux surgery for prevention of chronic lung allograft dysfunction (CLAD) onset after lung transplantation: The earlier the better before CLAD onset? A single-center series of 284 patientsAbdulmonem Hamid, Alexandre Vallée, Sophie Rong, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 2025
Trajectories of FEV<sub>1</sub> after lung transplantation and patient outcomesMarc Raynaud, Natalia Belousova, Matthieu Glorion, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Transplant International : Official Journal of the European Society for Organ Transplantation|March 15, 2018
Donor-specific HLA antibody-mediated complement activation is a significant indicator of antibody-mediated rejection and poor long-term graft outcome during lung transplantation: a single center cohort studyAntoine Roux, Kimberly A Thomas, Edouard Sage, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
First use of imlifidase desensitization in a highly sensitized lung transplant candidate: a case reportAntoine Roux, Vincent Bunel, Natalia Belousova, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
High Emergency Lung Transplantation: dramatic decrease of waiting list death rate without relevant higher post-transplant mortalityAntoine Roux, Laurence Beaumont-Azuar, Abdul Monem Hamid, et al.
Frontiers in Medicine|October 28, 2017
Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung TransplantationAntoine Roux, Ines Bendib Le Lan, Sonia Holifanjaniaina, et al.
JHLT Open|March 27, 2025
Antireflux surgery for prevention of chronic lung allograft dysfunction (CLAD) onset after lung transplantation: The earlier the better before CLAD onset? A single-center series of 284 patientsAbdulmonem Hamid, Alexandre Vallée, Sophie Rong, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 2025
Trajectories of FEV<sub>1</sub> after lung transplantation and patient outcomesMarc Raynaud, Natalia Belousova, Matthieu Glorion, et al.
Pageof 1